Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.002 |
| March 31, 2023 | 0.0036 |
| December 31, 2022 | 0.0043 |
| September 30, 2022 | 0.0039 |
| June 30, 2022 | 0.0055 |
| March 31, 2022 | 0.0062 |
| December 31, 2021 | 0.0079 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0079 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.583 |
| June 30, 2020 | 0.5667 |
| March 31, 2020 | 0.7878 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.4595 |
| September 30, 2019 | 0.3346 |
| June 30, 2019 | 0.4618 |
| March 31, 2019 | 0.4647 |
| December 31, 2018 | 0.484 |
| September 30, 2018 | 0.1615 |
| June 30, 2018 | 0.2691 |
| March 31, 2018 | 0.3103 |
| December 31, 2017 | 0.3694 |
| September 30, 2017 | 0.5735 |
| June 30, 2017 | 0.5214 |
| March 31, 2017 | 0.4488 |
| December 31, 2016 | 0.4314 |
| September 30, 2016 | 2.252 |
| June 30, 2016 | 2.656 |
| March 31, 2016 | -8.096 |
| December 31, 2015 | 24.12 |
| September 30, 2015 | 5.215 |
| June 30, 2015 | 4.471 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.099 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| LENZ Therapeutics, Inc. | 0.0026 |
| Impact BioMedical, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.944M |
| Total Liabilities (Quarterly) | 0.8615M |
| Shareholders Equity (Quarterly) | 8.082M |
| Current Ratio | 10.21 |